Methimazole (Tapazole) Cost in Alaska 2026

What Does Methimazole Actually Cost in Alaska?

Generic methimazole runs about $15 per month at Alaska retail pharmacies in 2026 when paid cash, while brand-name Tapazole carries a manufacturer list price near $80 per month. Savings cards and discount programs routinely bring both figures lower. The gap between $15 and $80 is almost entirely explained by choosing generic over brand, and most prescribers write for generic by default.

Methimazole is a thioamide antithyroid drug approved by the FDA for hyperthyroidism and pre-surgical or pre-radioiodine thyroid preparation [1]. It works by blocking thyroid peroxidase, the enzyme that catalyzes iodide oxidation and thyroid hormone synthesis [2]. Because it has been generic for decades, the supply chain is competitive and retail prices in most U.S. states, including Alaska, remain below $20 per month for the generic form.

Alaska presents unique access challenges. The state has fewer retail pharmacies per capita than the contiguous 48 states, and remote communities often rely on mail-order or telehealth-linked pharmacy networks. Shipping costs can add $5 to $15 per order for residents outside Anchorage, Fairbanks, or Juneau. Factor that into any price comparison you run against lower-48 online pharmacies.

The standard dose range studied in randomized controlled trials is 10 mg to 30 mg daily, titrated by free T4 and TSH response [3]. A 30 mg daily dose requires three 10 mg tablets, which triples the monthly pill count but rarely triples the cost because most pharmacies price methimazole per fill, not strictly per milligram.

At major chain pharmacies in Anchorage, the 30-day supply of methimazole 5 mg or 10 mg typically costs between $12 and $18 without any discount card. Using GoodRx or a similar coupon can push that below $10 at select locations. The FDA label for methimazole remains publicly accessible and confirms the approved indications and formulations [4].

Alaska Medicaid Coverage for Methimazole

Alaska Medicaid does not currently cover methimazole (Tapazole) on its preferred drug list. This means Medicaid-enrolled Alaskans cannot use their benefit to fill a standard retail methimazole prescription without a prior-authorization exception, and even then approval is not guaranteed.

The Alaska Division of Health Care Services publishes its Medicaid fee schedule and preferred drug list through the Alaska Department of Health [5]. Methimazole's absence from that list is a formulary decision, not a clinical one. The American Thyroid Association (ATA) 2016 guidelines recommend methimazole as the preferred antithyroid drug for nearly all hyperthyroid patients except during the first trimester of pregnancy, citing its lower risk of serious side effects compared with propylthiouracil [6]. The ATA states explicitly: "We recommend methimazole be used in virtually every patient who chooses antithyroid drug therapy, except during the first trimester of pregnancy." Despite this guideline endorsement, Alaska Medicaid has not added it to the covered list as of early 2026.

Medicaid enrollees have two practical paths. First, ask your prescriber to submit a prior-authorization request citing the ATA 2016 guideline and your documented hyperthyroidism diagnosis. Second, price the drug out of pocket, at $15 per month, generic methimazole may cost less than the time and friction involved in prior-authorization appeals. A third option, compounded methimazole from a 503A pharmacy, is discussed in its own section below.

Patients dually enrolled in Medicare and Medicaid should check their Medicare Part D plan separately. Part D formularies are set by individual plan sponsors, and some Alaska Part D plans do cover methimazole generics at Tier 1 or Tier 2 cost-sharing levels [7].

Compounded Methimazole in Alaska: Is It Legal?

Compounded methimazole from a state-licensed 503A pharmacy is legal in Alaska when prescribed for an individual patient with a documented medical need. The FDA's framework for 503A compounding pharmacies permits patient-specific compounding of non-commercially-available formulations or alternative doses and delivery forms [8].

The distinction between 503A and 503B matters here. A 503A pharmacy compounds for individual patients on a prescription-by-prescription basis and is primarily regulated by Alaska state pharmacy law. A 503B outsourcing facility compounds in larger batches and falls under more direct FDA oversight. Both types can serve Alaska patients, though 503A facilities are more commonly used in telehealth-linked thyroid programs [9].

Why would someone choose compounded methimazole over the generic tablet? Three common reasons: a physician-determined dose that does not match commercially available tablet strengths (e.g., 2.5 mg for pediatric titration), an alternative formulation such as a transdermal cream or oral suspension for patients with swallowing difficulties, or a telehealth program that bundles the cost of the compounded drug into a monthly membership fee, effectively making the medication $0 out of pocket.

Alaska's Board of Pharmacy licenses in-state compounding pharmacies and also permits Alaskans to receive compounded medications shipped from out-of-state 503A pharmacies that hold the appropriate licensure in their home state [10]. Patients should confirm that any mail-order compounding pharmacy they use is licensed in both its home state and registered to ship to Alaska before filling a prescription.

The FDA caution worth knowing: compounded drugs do not undergo the same pre-market efficacy and safety review as FDA-approved generics. For methimazole specifically, this is a lower-stakes concern because the active molecule is identical to the approved drug. Potency and sterility standards, however, vary by pharmacy, so using a PCAB-accredited compounder adds a layer of quality assurance [11].

Telehealth Prescribing of Methimazole in Alaska

Methimazole can be prescribed via telehealth in Alaska. Hyperthyroidism and Graves disease are not Schedule II-V controlled substance indications, so the prescribing rules that complicate telehealth for buprenorphine or testosterone do not apply here. A licensed physician or advanced practice provider holding an Alaska prescribing license can evaluate a patient via synchronous video visit and issue a methimazole prescription to any licensed Alaska pharmacy [12].

The Ryan Haight Online Pharmacy Consumer Protection Act, which governs controlled-substance telehealth prescribing, does not restrict non-controlled drugs. Methimazole prescriptions can therefore be sent to retail or mail-order pharmacies without an in-person visit requirement under federal law [13].

For Alaskans in remote communities, this is significant. A patient in Nome or Kodiak who would otherwise need to fly to Anchorage for an endocrinology appointment can complete a thyroid evaluation via telemedicine, receive a methimazole prescription the same day, and have it filled at a local pharmacy or shipped from a mail-order facility. Follow-up thyroid function testing (TSH, free T4) can be ordered through local labs and reviewed remotely.

HealthRX's telehealth platform serves Alaska patients for thyroid management. Initial consultations include thyroid panel review and, where appropriate, a methimazole prescription linked to a compounding pharmacy partner, which brings the per-month drug cost to $0 for qualifying patients enrolled in the membership program.

The monitoring framework used by HealthRX clinicians for methimazole initiation in Alaska telehealth patients follows the ATA 2016 guidelines: CBC with differential and liver function tests at baseline, repeated if the patient develops fever, pharyngitis, or jaundice, with TSH and free T4 checked every 4 to 6 weeks during dose titration and every 3 to 6 months once euthyroid [6].

Clinical Evidence Behind Methimazole

Methimazole's efficacy is well-established across decades of controlled data. The landmark Cooper 2005 review in the New England Journal of Medicine summarized the comparative trial data and confirmed methimazole's superiority to propylthiouracil for long-term outpatient antithyroid therapy in terms of both dosing convenience and side-effect profile [3]. Methimazole's longer half-life allows once-daily dosing, whereas propylthiouracil requires three-times-daily administration, a meaningful adherence advantage [3].

Remission rates after 12 to 18 months of methimazole therapy in Graves disease range from 40% to 60% in the published literature, with relapse rates of 50% to 60% within 12 months of stopping the drug in patients who do relapse [14]. The Methimazole in Graves Orbitopathy (EUGOGO) data and related European studies confirm that sustained biochemical euthyroidism during treatment correlates with lower relapse risk [15].

Agranulocytosis is the most serious adverse effect, occurring in approximately 0.2% to 0.5% of patients at doses above 40 mg/day [3]. Patients should be counseled to stop methimazole and seek same-day evaluation for any fever above 38.5 degrees Celsius or sore throat developing during treatment. The FDA label includes a black-box-adjacent warning about this risk [4]. Minor side effects including rash, urticaria, and arthralgias occur in 1% to 5% of patients and are often dose-dependent [16].

For pregnant patients, propylthiouracil is preferred in the first trimester because methimazole carries a rare but documented association with aplasia cutis and choanal atresia when used in the first 12 weeks of gestation [6]. After the first trimester, methimazole is reintroduced as the preferred agent given propylthiouracil's hepatotoxicity risk [17].

Insurance Coverage for Methimazole in Alaska

Private insurance coverage for methimazole in Alaska depends on your specific plan's formulary. Most commercial plans in Alaska, including those sold on the ACA marketplace, include generic methimazole at Tier 1 or Tier 2, meaning your cost-share is typically $5 to $20 per 30-day fill after your deductible is met [18].

Premera Blue Cross and Regence BlueShield of Alaska are two of the largest commercial insurers operating in the state. Both have historically listed generic methimazole on their standard formularies, though formulary status changes annually and patients should verify coverage for the current plan year before assuming coverage continues [19].

Employer-sponsored plans subject to ERISA are governed by federal law and set their own formularies. These vary widely. An employee at a large Anchorage employer may have $0 copay for methimazole, while a worker at a small business with a high-deductible health plan may pay full retail cost until their deductible resets.

For uninsured or underinsured Alaskans, the options in ranked order of likely lowest cost are: (1) generic methimazole with a GoodRx or RxSaver coupon at a chain pharmacy, targeting $8 to $12 per month; (2) NeedyMeds or RxAssist patient-assistance programs for brand Tapazole if income qualifies; (3) compounded methimazole through a telehealth-linked program at $0; and (4) the Pfizer savings card for Tapazole brand, which may reduce out-of-pocket cost for commercially insured patients but generally does not apply to government-insured patients [20].

Pfizer Savings Card and Generic Manufacturer Coupons in Alaska

The Pfizer savings card for Tapazole is available to commercially insured patients who are not enrolled in Medicaid, Medicare, or any other federal or state healthcare program. Eligible patients may pay as little as $0 to $25 per month for brand Tapazole through this program [20]. The card is applied at the pharmacy counter and processed as a secondary payer.

Generic methimazole is manufactured by multiple companies, including Amneal, Lannett, and Cadista. These generic manufacturers do not typically offer branded savings cards, but the competitive generic market keeps retail prices low without any coupon. GoodRx prices at Costco, Walmart, and Fred Meyer pharmacies in Anchorage generally fall between $8 and $14 for a 30-day supply of generic methimazole 10 mg [21].

NeedyMeds maintains a database of patient-assistance programs for thyroid medications and updates it regularly [22]. Income-qualifying patients may receive free brand Tapazole directly from Pfizer through their patient-assistance program by submitting proof of income and a prescription.

Alaska-Specific Pharmacy Access and Pricing Factors

Alaska's geography affects pharmacy pricing and access in ways that mainland patients do not face. Rural Health Clinics and Indian Health Service facilities in Alaska sometimes carry methimazole in their formularies and can dispense to enrolled patients at reduced or no cost [23]. Alaska Native Tribal Health Consortium (ANTHC) pharmacies, for example, serve Alaska Native and American Indian patients and operate under the IHS drug pricing structure, which provides medications at cost.

Mail-order pharmacies licensed to ship to Alaska include Express Scripts, CVS Caremark, and OptumRx. Each of these offers 90-day supplies, which typically lowers the per-dose cost by 10% to 20% compared with 30-day retail fills [24]. A 90-day supply of generic methimazole at a mail-order pharmacy may cost $25 to $35 total, equivalent to $8 to $12 per month.

For communities accessible only by air or sea, shipping delays are a real clinical risk. Patients on methimazole should maintain at least a 30-day buffer supply and coordinate with their prescriber to send refill prescriptions to mail-order pharmacies 3 to 4 weeks before the current supply runs out. Abrupt discontinuation of methimazole in a patient with uncontrolled Graves disease can precipitate thyroid storm, a life-threatening emergency with mortality rates reported up to 10% to 20% in some case series [25].

Monitoring Labs and What They Cost in Alaska

Methimazole therapy requires regular thyroid function testing. TSH and free T4 tests ordered through Alaska Regional Hospital or Providence Alaska Medical Center's outpatient lab typically cost $30 to $80 per panel without insurance, depending on the draw site and whether the specimen is processed locally or sent to a reference laboratory in Seattle or Portland.

The ATA recommends checking TSH and free T4 every 4 to 6 weeks during the initial titration phase [6]. For a patient titrating over 6 months, that means 3 to 4 lab panels at potentially $30 to $80 each, adding $90 to $320 in lab costs to the first-year total cost of methimazole therapy. Telehealth programs that bundle lab ordering with the visit fee can reduce this burden if they contract with local Alaska lab draw sites.

CBC with differential is recommended at baseline and when symptoms of agranulocytosis appear [4]. Routine serial CBCs are not recommended by most guidelines because agranulocytosis typically presents acutely rather than developing gradually enough to be caught by scheduled monitoring [6]. Liver function tests should be obtained if cholestatic jaundice or hepatitis symptoms develop, given methimazole's rare hepatotoxic potential [16].

Quest Diagnostics and LabCorp both operate patient service centers in Anchorage and Fairbanks and can process methimazole-related thyroid panels. Quest's self-pay thyroid panel (TSH plus free T4) through its QuestDirect consumer program runs approximately $49 to $79 in 2026 [26].

Cost Comparison: Methimazole vs. Radioactive Iodine vs. Surgery in Alaska

Methimazole is by far the least expensive first-line treatment for Graves disease in Alaska. Radioactive iodine (RAI) therapy, the alternative to antithyroid drugs in non-pregnant adults, requires access to a nuclear medicine facility. In Alaska, RAI is available at a small number of Anchorage facilities. The out-of-pocket cost for RAI without insurance runs $1,000 to $3,000 for the dose and associated facility fees [27]. After RAI, most patients develop hypothyroidism and require lifelong levothyroxine, adding ongoing medication costs.

Thyroid surgery (total or partial thyroidectomy) in Alaska averages $15,000 to $40 to 000 in facility and surgeon fees before insurance, based on procedure cost data from Alaska's All Payer Claims Database [28]. Surgery also carries perioperative risks including hypoparathyroidism and recurrent laryngeal nerve injury.

For patients who achieve remission with methimazole, total 18-month treatment cost at $15 per month is $270 in drug costs alone. Even adding lab costs of $300 to $400 over the treatment course, total methimazole therapy runs well under $1,000 for most Alaskans, making it economically dominant over the procedural alternatives for patients who are candidates for medical therapy.